Alina Pszczółkowska is a medical graduate with a distinguished diploma in management from Polish Open University and Oxford Brookes University. Since 1997, she’s been involved with clinical research – working in Poland and in various global roles
After spending some time as acting physician she joined pharma industry and AstraZeneca in 1999, where she has held various leadership roles in clinical operations across site, study and programm management leading projects and organisations across the globe.
She also worked in Gothenburg, Sweden, overseeing delivery of cardiovascular, kidney, and gastrointestinal portfolio.
As of 2023, Alina is the Head of Late Phase Program Management organization in Respiratory and Immunology.
Alina is also the Site Leader of for AstraZeneca Cross functional site in Poland, and Vice-President at AstraZeneca Pharma Poland.
Central City Clinical Hospital of Ivano-Frankivsk City Council
CEO of a clinical trials unit that was founded from scratch in 2017 at a state hospital in Ivano-Frankivsk, Ukraine and now developed into an organization with 15-20 multi-specialty trials running simultaneously with a potential to grow. One of the founders and current Board member of the Ukrainian Association for Clinical Research. Adept ENT doctor and principal investigator in otolaryngology with ability to work in a multidisciplinary team, experience in delivering patient care in both public and private settings with the use of the latest industry equipment and technology, as well as establishing own private practice. Proactive and dedicated to seeking opportunities for cooperation with international specialists. Strong knowledge of Ukrainian medical policy landscape through working with the Ministry of Health of Ukraine on reforming healthcare services. Proven track record of planning and executing projects in medical sphere.
Best wishes,
Andreia Cruz e Silva is passionate about working with patient data and looking for innovative ways to improve the field of Data Management in Clinical Research. Has gained experience on Sponsor-CRO interaction as a Clinical Data Manager and Data Analyst at the German midsize pharmaceutical company medac GmbH. With a strong background in scientific research and medical sciences, Andreia completed a Masters in neuroscience (University of Lisbon) and a PhD in biochemistry (Free University of Berlin).
Elvira Suniega-Tolentino is the Clinical Project Manager Team Leader for Singapore at the Nestlé Clinical Research Unit, responsible for end-to-end clinical project management and operational activities of Nestlé corporate clinical trials serving all Business Units. At the Clinical Research Unit, she is also leading the Vendor/Out-sourcing activities where she drives strategic partnerships with CROs, Universities, Laboratories, etc. Prior to joining Nestlé, Elvira was the Area Clinical Operations Manager for Abbott Nutrition R&D, Asia Pacific Center in Singapore for 11 years. Over the years, she has sharpened her expertise in the industry, bringing in thoughtful and strong competency into Nestlé’s clinical projects. The combination of her expertise, leadership and passion for innovation strongly supports the continuous improvement and excellence of Nestlé’s clinical research activities to further unlock the power of food to enhance the quality of life for every consumers, today and for generations to come.
Dr. Bhargava Reddy has over 16 years of experience working in the pharmaceutical industry. He is currently Head of Advanced Insights at Janssen Pharmaceutical supporting clinical operations by providing data science solutions. Prior to this role, he was Associate Director of Advanced Analytics at UCB. In this role, he was responsible for the development and application of machine learning methodologies supporting clinical decision making within Immunology and. He was also leading the analytics work supporting Risk Based Monitoring. Prior to this role, he managed a statistical programming group and was also overseeing a large statistical programming group offshore.
Dr. Reddy has published several methodology papers in peer reviewed academic journals in the areas of machine learning and deep learning. He is actively involved as an associate editor for the Frontiers in AI journal and also as a reviewer on several journals. He has a Ph.D. from Oklahoma State University and MS from Northwestern University.
Dawn has over 25 years of experience in the pharmaceutical industry. She has worked within every level of clinical data management, from Data Coordinator to Senior Director where she participated in or had oversight for more than 250 clinical trials. During her time in the industry, she has provided consultation to organizations on clinical trial conduct, best practices in Data Management and data capture as well as developed standardized libraries and templates to support the adoption of CDISC standards. She is an active member of SCDM as a GCDMP SME, course designer and webinar presenter as well as former Co-Chair of the annual conference (2018-2021) and currently serves on the SCDM Board of Trustees. Dawn is involved as a member of the CDISC-CDASH core team, Diabetes sub-team, CDASH CFAST Expanded Leadership Team and former Co-Chair of the CRF Library project. Dawn currently holds the position of Vice President, BD Operations, where she supports business development as a Clinical Subject Matter Expert for both software and Biometrics services as well as overseeing the Proposals and Solution Consulting departments.
As Vice President, Business Development at Curebase, Wayne leverages more than a decade of experience in clinical research across both clinical operations and strategic sales to identify new areas for growth within the company. He is a key member of the leadership team responsible for defining the company’s go to market strategy and value proposition across the many segments of the pharmaceuticals and device research industry. Before joining Curebase, Wayne served as Vice President at mid-sized Florida based CRO Biorasi, where he helped to lead that company to a successful acquisition by a private equity partner in 2018. Wayne holds an MBA and B.S. degree in Neurobiology and is the author of several peer-reviewed papers in prostate cancer and premature ovarian failure. Wayne resides in Miami, Florida.
